Norbert Gleicher1, Mario V Vega2, Sarah K Darmon3, Andrea Weghofer4, Yan-Guan Wu3, Qi Wang3, Lin Zhang3, David F Albertini5, David H Barad6, Vitaly A Kushnir7. 1. Center for Human Reproduction, New York, New York; Foundation for Reproductive Medicine, New York, New York; Stem Cell Biology and Molecular Embryology Laboratory, Rockefeller University, New York, New York. Electronic address: ngleicher@thechr.com. 2. Center for Human Reproduction, New York, New York; Department of Obstetrics and Gynecology, Mount Sinai St. Lukes-Roosevelt Hospital, New York, New York. 3. Center for Human Reproduction, New York, New York. 4. Center for Human Reproduction, New York, New York; Vienna University School of Medicine, Vienna, Austria. 5. Center for Human Reproduction, New York, New York; Department of Molecular and Integrative Physiology, University of Kansas School of Medicine, Wichita, Kansas. 6. Center for Human Reproduction, New York, New York; Foundation for Reproductive Medicine, New York, New York; Department of Obstetrics and Gynecology, Albert Einstein College of Medicine, Bronx, New York. 7. Center for Human Reproduction, New York, New York; Department of Obstetrics and Gynecology, Wake Forest University, Winston-Salem, North Carolina.
Abstract
OBJECTIVE: To determine live-birth rates (LBRs) at various ages in very poor prognosis patients, who are defined as poor responders under the Bologna criteria. DESIGN: Retrospective cohort study. SETTING: Academically affiliated private fertility center. PATIENT(S): Among 483 patients, who under the Bologna criteria (three or fewer oocytes, >40 years of age, and/or antimüllerian hormone [AMH] <1.1 ng/mL [2/3 criteria minimum]) were poor responders, 278 (381 fresh IVF cycles) qualified for the study because they had at least one embryo on day 3 for transfer. INTERVENTION(S): IVF cycles in women with low functional ovarian reserve, involving androgen and CoQ10 supplementation and ovarian stimulation with daily gonadotropin dosages of 300-450 IU of FSH and 150 IU of hMG in microdose agonist cycles. MAIN OUTCOME MEASURE(S): Age-specific LBRs per ET. RESULT(S): Ages did not differ between nonelective (ne) single ET (SET), ne2-ET, and ne ≥ 3-ET cycles (41.3 ± 3.9, 41.7 ± 3.1, and 42.4 ± 2.1 years, respectively). Patients with neSETs demonstrated significantly lower AMH and higher FSH levels and required higher gonadotropin dosages than ne2-ET and ne ≥ 3-ET patients. LBRs declined with age. Above age 42, three or more embryos are required to achieve reasonable LBRs and two or more to avoid futility under American Society for Reproductive Medicine (ASRM) guidelines. CONCLUSION(S): Very poor prognosis patients can still achieve acceptable pregnancy rates at least till their mid-40s if they reach ET. The degree to which egg donation is emphasized as the only treatment option in such patients, therefore, requires reconsideration. Above age 42, at least two, and preferably three embryos, are however required to exceed futility, as defined by ASRM.
OBJECTIVE: To determine live-birth rates (LBRs) at various ages in very poor prognosis patients, who are defined as poor responders under the Bologna criteria. DESIGN: Retrospective cohort study. SETTING: Academically affiliated private fertility center. PATIENT(S): Among 483 patients, who under the Bologna criteria (three or fewer oocytes, >40 years of age, and/or antimüllerian hormone [AMH] <1.1 ng/mL [2/3 criteria minimum]) were poor responders, 278 (381 fresh IVF cycles) qualified for the study because they had at least one embryo on day 3 for transfer. INTERVENTION(S): IVF cycles in women with low functional ovarian reserve, involving androgen and CoQ10 supplementation and ovarian stimulation with daily gonadotropin dosages of 300-450 IU of FSH and 150 IU of hMG in microdose agonist cycles. MAIN OUTCOME MEASURE(S): Age-specific LBRs per ET. RESULT(S): Ages did not differ between nonelective (ne) single ET (SET), ne2-ET, and ne ≥ 3-ET cycles (41.3 ± 3.9, 41.7 ± 3.1, and 42.4 ± 2.1 years, respectively). Patients with neSETs demonstrated significantly lower AMH and higher FSH levels and required higher gonadotropin dosages than ne2-ET and ne ≥ 3-ET patients. LBRs declined with age. Above age 42, three or more embryos are required to achieve reasonable LBRs and two or more to avoid futility under American Society for Reproductive Medicine (ASRM) guidelines. CONCLUSION(S): Very poor prognosis patients can still achieve acceptable pregnancy rates at least till their mid-40s if they reach ET. The degree to which egg donation is emphasized as the only treatment option in such patients, therefore, requires reconsideration. Above age 42, at least two, and preferably three embryos, are however required to exceed futility, as defined by ASRM.
Authors: Norbert Gleicher; Sarah K Darmon; Vitaly A Kushnir; Andrea Weghofer; Qi Wang; Lin Zhang; David F Albertini; David H Barad Journal: Endocrine Date: 2016-08-10 Impact factor: 3.633
Authors: Heather Hipp; Sara Crawford; Jennifer F Kawwass; Sheree L Boulet; David A Grainger; Dmitry M Kissin; Denise Jamieson Journal: J Assist Reprod Genet Date: 2017-04-28 Impact factor: 3.412
Authors: Vitaly A Kushnir; David B Seifer; David H Barad; Aritro Sen; Norbert Gleicher Journal: J Assist Reprod Genet Date: 2017-06-22 Impact factor: 3.412
Authors: Vitaly A Kushnir; David H Barad; David F Albertini; Sarah K Darmon; Norbert Gleicher Journal: Reprod Biol Endocrinol Date: 2017-01-10 Impact factor: 5.211
Authors: Yan-Guang Wu; David H Barad; Vitaly A Kushnir; Qi Wang; Lin Zhang; Sarah K Darmon; David F Albertini; Norbert Gleicher Journal: J Ovarian Res Date: 2018-03-16 Impact factor: 4.234